0000904454-19-000115.txt : 20190129
0000904454-19-000115.hdr.sgml : 20190129
20190129204734
ACCESSION NUMBER: 0000904454-19-000115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190125
FILED AS OF DATE: 20190129
DATE AS OF CHANGE: 20190129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van Deventer Sander
CENTRAL INDEX KEY: 0001543084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36294
FILM NUMBER: 19550140
MAIL ADDRESS:
STREET 1: POSTBUS 5187
CITY: NAARDEN
STATE: P7
ZIP: 1410 AD
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: uniQure N.V.
CENTRAL INDEX KEY: 0001590560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
BUSINESS PHONE: 1-339-970-7000
MAIL ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
FORMER COMPANY:
FORMER CONFORMED NAME: uniQure B.V.
DATE OF NAME CHANGE: 20131030
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-01-25
0001590560
uniQure N.V.
QURE
0001543084
van Deventer Sander
C/O UNIQURE N.V.
PAASHEUVELWEG 25A
AMSTERDAM
P7
1105BP
NETHERLANDS
0
1
0
0
Chief Scientific Officer
Ordinary Shares
2019-01-25
4
A
0
5589
0
A
30658
I
See footnote
Ordinary Shares
2019-01-25
4
A
0
10913
0
A
41571
I
See footnote
Stock Option (Right to Buy)
31.71
2019-01-25
4
A
0
18325
0
A
2029-01-25
Ordinary Shares
18325
18325
D
Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.
Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners ("FCP"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP. The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Represents performance-based restricted share units ("PRSUs") granted on January 26, 2018 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 25, 2019. Each PRSU represents the contingent right to receive one Ordinary Share.
The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.
/s/ Christian Klemt, Attorney-in-Fact
2019-01-29